Literature DB >> 7515594

Short report: detection of Entamoeba histolytica and E. dispar directly in stool.

R Haque1, L M Neville, S Wood, W A Petri.   

Abstract

Current diagnosis of Entamoeba histolytica infection requires the direct microscopic identification of the parasite, a technique that is insensitive and cannot distinguish pathogenic E. histolytica from noninvasive E. dispar. Enzyme-linked immunosorbent assay (ELISA) antigen detection tests were developed to distinguish E. histolytica from E. dispar infection in stool specimens. The ELISA result for E. histolytica antigen was positive in 26 of 27 E. histolytica-positive stool specimens, three of 25 E. dispar-positive stools, and one of 30 stools with other or no intestinal parasites, giving a specificity and sensitivity for the detection of E. histolytica infection of 93% and 96%, respectively. The assay result used to detect both E. dispar and E. histolytica was positive in 26 of 27 E. histolytica-positive stools, 19 of 25 E. dispar-positive stools, and one of 30 stools negative by microscopy and culture for Entamoeba, giving a specificity and sensitivity of 97% and 87%, respectively. Because these ELISAs can be completed in several hours, they offer promise as rapid and sensitive means of detecting amebic infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515594     DOI: 10.4269/ajtmh.1994.50.595

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

1.  Preparation of a monoclonal antibody specific for Entamoeba dispar and its ability to distinguish E. dispar from E. histolytica.

Authors:  H Tachibana; S Kobayashi; Y Kaneda; T Takeuchi; T Fujiwara
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Preparation of recombinant human monoclonal antibody Fab fragments specific for Entamoeba histolytica.

Authors:  H Tachibana; X J Cheng; K Watanabe; M Takekoshi; F Maeda; S Aotsuka; Y Kaneda; T Takeuchi; S Ihara
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Evaluation of an antigen-capture enzyme immunoassay for detection of Entamoeba histolytica in stool samples.

Authors:  T Jelinek; G Peyerl; T Löscher; H D Nothdurft
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

4.  Simple differential detection of Entamoeba histolytica and Entamoeba dispar in fresh stool specimens by sodium acetate-acetic acid-formalin concentration and PCR.

Authors:  H Troll; H Marti; N Weiss
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

5.  Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum antigens in human fecal specimens using the triage parasite panel enzyme immunoassay.

Authors:  L S Garcia; R Y Shimizu; C N Bernard
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 6.  Waterborne protozoan pathogens.

Authors:  M M Marshall; D Naumovitz; Y Ortega; C R Sterling
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

7.  Seroprevalence of Entamoeba histolytica infection in China.

Authors:  Bin Yang; Yingdan Chen; Liang Wu; Longqi Xu; Hiroshi Tachibana; Xunjia Cheng
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

Review 8.  Pathogenesis of intestinal amebiasis: from molecules to disease.

Authors:  M Espinosa-Cantellano; A Martínez-Palomo
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

9.  An improved colorimetric PCR-based method for detection and differentiation of Entamoeba histolytica and Entamoeba dispar in feces.

Authors:  D Britten; S M Wilson; R McNerney; A H Moody; P L Chiodini; J P Ackers
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

10.  Rapid diagnosis of Entamoeba infection by using Entamoeba and Entamoeba histolytica stool antigen detection kits.

Authors:  R Haque; L M Neville; P Hahn; W A Petri
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.